KembaliKembaliNet income before discontinued operations dari DASHENLIN PHARMACEUTICAL GROUP.
Data tahunan
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
0,00
300,00 M
600,00 M
900,00 M
1,20 B
Periode
Nilai
Perubahan
% Perubahan
TTM
850,26 M
−316,24 M
−27,11%
2023
1,17 B
+130,77 M
+12,63%
2022
1,04 B
+244,49 M
+30,90%
2021
791,23 M
−270,95 M
−25,51%
2020
1,06 B
+359,52 M
+51,17%
2019
702,66 M
+171,03 M
+32,17%
Data per kuartal
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−170,00 M
0,00
170,00 M
340,00 M
510,00 M
Periode
Nilai
Perubahan
% Perubahan
Q3 '24
200,53 M
−58,61 M
−22,62%
Q2 '24
259,14 M
−139,31 M
−34,96%
Q1 '24
398,45 M
+406,31 M
-
Q4 '23
−7,86 M
−264,79 M
−103,06%
Q3 '23
256,93 M
−163,74 M
−38,92%
Q2 '23
420,67 M
−76,08 M
−15,32%
Q1 '23
496,75 M
+384,27 M
+341,61%
Q4 '22
112,49 M
−96,56 M
−46,19%